浙江亨通控股股份有限公司为全资孙公司亨通（内蒙古）生物科技有限公司提供重大担保

证券代码：600226
证券简称：亨通股份
公告编号：2026-032
公告日期：2026年5月26日

一、报告要点梳理

• 担保事项：浙江亨通控股股份有限公司（以下简称“公司”）为全资孙公司亨通（内蒙古）生物科技有限公司（以下简称“亨通生物”）向中信银行苏州分行申请不超过3亿元人民币（30,000万元）的贷款提供连带责任保证。本次担保无反担保安排。
• 担保余额及额度：截至本次公告，实际已提供的担保余额为575万元，本次担保后累计担保总额为182,664.58万元，占公司最近一期经审计净资产的50.31%。
• 董事会及股东会授权：本次担保在公司第九届董事会第二十七次会议及2025年第四次临时股东会批准的担保总额度（5亿元人民币）范围内，无需再次召开董事会或股东会审议。
• 被担保人信息：
  • 成立时间：2025年3月18日
  • 注册资本：1亿元人民币
  • 法人代表：李海江
  • 主营业务：饲料添加剂、兽药、食品添加剂生产与销售，货物与技术进出口等
  • 财务状况（截至2026年3月31日，未经审计）：资产总额2.16亿元，负债总额1.25亿元，净资产9,141万元，营业收入为零，净利润为-493.87万元（亏损）
• 担保合同主要条款：
  • 保证方式：连带责任保证
  • 保证金额：不超过3亿元
  • 保证期间：债务履行期限届满之日起三年，每一具体业务合同项下单独计算
  • 保证范围：包括主债权、利息、罚息、复利、违约金、损害赔偿金、迟延履行期间的债务利息、迟延履行金及实现债权的各项费用
• 风险提示：
  • 目前对外担保余额占净资产比例为50.31%，未超过50%和100%阈值，无逾期担保。
  • 被担保公司尚未产生营业收入且存在亏损，需关注其未来经营及资金偿还能力。
  • 公司担保均为下属控制企业，不涉及控股股东、实际控制人及其关联人。

二、对股东及股价的影响分析

• 资金用途及战略影响：该担保将有助于亨通生物的经营发展和资金需求，推动公司转型升级，有利于公司整体战略布局和业务板块的日常经营。
• 风险控制：公司表示担保风险可控，不会对公司正常经营和业务发展造成不利影响。但需关注被担保企业的经营状况和持续亏损可能带来的未来风险。
• 价格敏感因素：
  • 本次担保金额巨大（3亿元），累计担保总额达到净资产50%以上，若未来被担保企业不能按期还款，公司可能面临较大财务风险。
  • 被担保企业目前尚未产生营业收入且亏损，若后续经营状况未改善，担保风险进一步加大，可能影响公司估值与股价。
  • 本次担保在股东会授权范围内，没有违规或超额担保行为，增强投资人信心。

三、详细信息与投资者需关注事项

• 公司累计对外担保总额为182,664.58万元，均为对子公司担保，无逾期担保。
• 被担保企业为公司全资孙公司，主营业务具有成长空间，但需关注其财务亏损状况。
• 公司董事会与股东会已充分授权并审议担保额度，流程合规。
• 本次担保无反担保，若发生风险，公司需独立承担责任。

四、结论

本次公告属于重大担保事项，涉及金额巨大及对净资产占比高，且被担保企业目前处于亏损状态，具有较高的价格敏感性和潜在风险。投资者需密切关注亨通生物后续经营状况及资金偿还能力，担保风险的变化可能对公司股价产生影响。

免责声明：本文仅为信息披露及投资参考，不构成任何投资建议。投资者需结合自身风险偏好及实际情况进行决策，相关风险请自行承担。

Zhejiang Hengtong Holdings Co., Ltd. Provides Major Guarantee for Wholly-Owned Grandson Company Hengtong (Inner Mongolia) Biotechnology Co., Ltd.

Stock Code: 600226
Stock Name: Hengtong Co., Ltd.
Announcement No.: 2026-032
Date: May 26, 2026

Key Highlights of the Report

• Guarantee Arrangement: Zhejiang Hengtong Holdings Co., Ltd. (“the Company”) acts as guarantor for its wholly-owned grandson company Hengtong (Inner Mongolia) Biotechnology Co., Ltd. (“Hengtong Bio”) in a loan application of up to RMB 300 million (30,000,000 yuan) to CITIC Bank Suzhou Branch, providing a joint liability guarantee. No counter-guarantee is involved.
• Guarantee Balance and Limit: Actual guarantee balance is RMB 5.75 million prior to this, and after this guarantee, total guarantee amount reaches RMB 1,826.65 million, accounting for 50.31% of the Company’s latest audited net assets.
• Board and Shareholder Authorization: This guarantee falls within the Board and Shareholder authorized limit (RMB 500 million), so no additional Board or Shareholder meetings are needed.
• Information about the Guaranteed Entity:
  • Established: March 18, 2025
  • Registered Capital: RMB 100 million
  • Legal Representative: Li Haijiang
  • Main Business: Production and sales of feed additives, veterinary drugs, food additives, import/export of goods and technology, etc.
  • Financials (as of March 31, 2026, unaudited): Total assets RMB 216.27 million, liabilities RMB 124.86 million, net assets RMB 91.41 million, revenue nil, net loss RMB -4.94 million
• Guarantee Contract Key Terms:
  • Guarantee Type: Joint liability guarantee
  • Guarantee Amount: Up to RMB 300 million
  • Guarantee Period: Three years from each underlying debt’s maturity date
  • Scope: Principal, interest, late fees, compound interest, penalty, compensation, overdue interest, overdue payment, cost of enforcing creditor’s rights, and all other payable fees
• Risk Warning:
  • Current external guarantees account for 50.31% of net assets, below critical thresholds (50% and 100%), and no overdue guarantees exist.
  • The guaranteed company has not generated revenue and is incurring losses; future operational and repayment capability need monitoring.
  • All guarantees are for controlled subsidiaries, none for controlling shareholders or their affiliates.

Impact Analysis for Shareholders and Share Price

• Strategic Implications: The guarantee supports Hengtong Bio’s business development and funding needs, aiding the Company’s strategic transformation and daily operations.
• Risk Control: The Company asserts risk is manageable and will not adversely affect normal operations, but sustained losses at Hengtong Bio may elevate future risks.
• Price Sensitive Factors:
  • Large guarantee amount (RMB 300 million); total guarantees exceed 50% of net assets. If Hengtong Bio fails to repay, the Company faces significant financial exposure.
  • Guaranteed entity is currently loss-making and has no revenue; unremedied financial performance may increase guarantee risk and impact Company valuation and share price.
  • Guarantee is within authorized range, no violation or excessive guarantee, which may reassure investors.

Detailed Information & Investor Focus Points

• Total external guarantees RMB 1,826.65 million, all for subsidiaries, no overdue guarantees.
• Guaranteed company is wholly-owned, business has growth potential but financial losses warrant attention.
• Full Board and Shareholder authorization has been obtained; procedures are compliant.
• No counter-guarantee; Company bears sole responsibility if risk materializes.

Conclusion

This announcement constitutes a major guarantee event, involving substantial amounts and high net asset ratios. Given the guaranteed company’s current loss-making status, it is highly price sensitive and risky. Investors should closely monitor Hengtong Bio’s future business performance and repayment capability, as changes in guarantee risk may affect the Company’s share price.

Disclaimer: This article is for information disclosure and investment reference only, and does not constitute any investment advice. Investors should make decisions based on their own risk tolerance and actual conditions. All risks are borne by the investor.

View 亨通股份 Historical chart here